ClinCalc Pro
Menu
Very potent topical corticosteroid Pregnancy: Avoid unless absolutely necessary. Significant risk of systemic absorption.

Clobetasol Propionate

Brand names: Dermovate, Clarelux

Adult dose

Dose: Apply thinly once or twice daily for up to 4 weeks
Route: Topical (cream, ointment, or scalp foam)
Frequency: Once or twice daily
Max: 50 g/week (body); never exceed
0.05% (very potent — highest potency class). Used for severe psoriasis (non-facial), severe eczema, lichen planus, discoid lupus. Max 4 weeks continuous use then step down. Face and flexures: AVOID. Annual cumulative dose maximum 50 g.

Paediatric dose

Route: Topical
Frequency: Once daily
Max: Avoid in children <1 year; use only under specialist guidance in children
Use only under specialist supervision in children. Very high systemic absorption risk in children. Rarely justified in paediatric practice — prefer lower potency. Annual cumulative dose much lower.

Dose adjustments

Renal

No systemic adjustment for topical use.

Hepatic

No systemic adjustment for topical use.

Clinical pearls

  • Reserve for severe, treatment-resistant conditions only
  • Max 4 weeks then review — step down to less potent steroid
  • DO NOT use on face, groin, axillae — very high absorption
  • Scalp foam (Clarelux) useful for scalp psoriasis — less systemic absorption than other formulations
  • Annual cumulative limit: 50 g total per year to prevent systemic effects

Contraindications

  • All contraindications of topical steroids apply
  • Face, flexures, or large body surface areas
  • Children <1 year

Side effects

  • All side effects of potent steroids (more severe due to high potency)
  • Significant HPA axis suppression with excessive use
  • Skin atrophy, striae (irreversible)
  • Cushing's syndrome (systemic absorption with misuse)

Interactions

  • Occlusive dressings significantly increase systemic absorption

Monitoring

  • Skin integrity
  • Body weight
  • Blood glucose
  • Signs of adrenal suppression (prolonged large-area use)

Reference: BNFc; BNF; BAD Psoriasis Guidelines; BAD Lichen Planus Guidelines. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.